Blume Capital Management’s AB InBev BUD Stock Holding History

Blume Capital Management’s Portfolio BUD Stock Details BUD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3	Closed	-$207	–	365
2025 Q2	$207	Buy	+3	New	+$201	﹤0.01%	414

Other funds holding BUD

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Gates Foundation Trust Kirkland, Washington $31.7B AUM 20.52% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Blume Capital Management's BUD Position: Q3 2025 in Review

Blume Capital Management sold out of AB InBev (BUD) in Q3 2025, closing a stake of 3 shares — an estimated $207 sold.

Blume Capital Management first reported a position in BUD in Q2 2025 and held it in 1 quarter. The position peaked at $207 in Q2 2025. 481 funds tracked by Wall St. Rank hold BUD as of Q3 2025.

Blume Capital Management reported no remaining AB InBev position as of Q3 2025 after selling out during the quarter.
Blume Capital Management sold 3 AB InBev shares in Q3 2025, an estimated $207.
Blume Capital Management first reported a position in AB InBev in Q2 2025 and held it in 1 quarter.
Blume Capital Management's AB InBev position peaked at $207 in Q2 2025.
481 funds tracked by Wall St. Rank held AB InBev as of Q3 2025.

Based on Blume Capital Management's 13F filing for Q3 2025, filed 6 Nov 2025.